IDIOPATHIC PULMONARY HYPERTENSION – CASE PRESENTATION

Kristina Bulatović ,
Kristina Bulatović
Contact Kristina Bulatović

Faculty of Medicine, University in Pristina , Pristina , Serbia

Vladan Perić ,
Vladan Perić

Faculty of Medicine , University in Pristina , Pristina , Serbia

, KBC Priština , Priština , Serbia

Maja Šipić ,
Maja Šipić

Faculty of Medicine , University in Pristina , Pristina , Serbia

, KBC Priština , Priština , Serbia

Jovana Milošević ,
Jovana Milošević

Faculty of Medicine , University of Priština - Kosovska Mitrovica , Kosovska Mitrovica , Serbia

Erdin Mehmedi ,
Erdin Mehmedi

Faculty of Medicine , University of Priština - Kosovska Mitrovica , Kosovska Mitrovica , Serbia

, Clinical Hospital Center , Kosovska Mitrovica , Serbia

Sanja Jovanović
Sanja Jovanović

Faculty of Medicine, University of Priština - Kosovska Mitrovica , Kosovska Mitrovica , Serbia

, Clinical Hospital Center , Kosovska Mitrovica , Serbia

Published: 15.02.2025.

Volume 52, Issue 3 (2023)

pp. 22-25;

https://doi.org/10.70949/pramed202503013B

Abstract

Pulmonary hypertension (PH) is a hemodynamic condition characterized by a mean pulmonary artery pressure (mPAP) ≥ 25 mmHg at rest, pulmonary arterial wedge pressure (PAWP) ≤ 15 mmHg, and pulmonary vascular resistance (PVR) > 240 dyn·s·cm⁵. The annual incidence of pulmonary arterial hypertension (PAH) is approximately 3–10 new cases per million adults. It is estimated that the prevalence of pulmonary hypertension in individuals over 65 years of age is around 10%.The aim of this study is to present the case of a female patient with progressive dyspnea in whom PAH remained undiagnosed for a prolonged period.A 74-year-old female patient, M.P., was hospitalized in the Coronary Care Unit of the Clinical Center in Kosovska Mitrovica due to symptoms of shortness of breath, choking, fatigue, leg swelling, and weakness. The admission ECG revealed: sinus rhythm, normal axis, high R wave in V2, ST depression, and negative T waves in leads II, III, aVF, and V4–V5. Echocardiography findings showed right ventricular enlargement (2.9 cm), pulmonary artery dilation (3.3 cm), 1–2+ pulmonary regurgitation, and 3+ tricuspid regurgitation, with a systolic pulmonary artery pressure (SPAP) of up to 126 mmHg. The right ventricle measured 5.3 cm in the 4Ch view, with a TAPSE of 1.8 cm. Right heart catheterization revealed the following pressures: PA 78/34/57 mmHg, RV 74/8/10 mmHg, RA 6/6/7 mmHg, CO 4.3 l/min, and LV 99/10/8 mmHg. Although primary pulmonary hypertension is predominantly a disease of younger individuals, it should also be considered in older patients presenting with progressive dyspnea in the absence of structural heart disease.

Keywords

References

1.
Galie N, Humbert M, Vachiery JL. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2015;37:67–119.
2.
Galie N, Humbert M, Vachiery JL. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC. International Society for Heart and Lung Transplantation (ISHLT) Eur Respir J. 2015;46:903–75.
3.
Hoeper MM, Humbert M, Souza R. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4:306–22.
4.
Hoeper MM, Huscher D, Pittrow D. Incidence and prevalence of pulmonary arterial hypertension in Germany. Int J Cardiol. 2016;203:612–3.
5.
Hoeper MM, Huscher D, Ghofrani HA. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013;168:871–80.
6.
Rosenkranz S, Gibbs JS, Wachter R, Marco T, Vonk-Noordegraaf A, Vachiery JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016;37:942–54.
7.
Cannon JE, Su L, Kiely DG. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom national cohort. Circulation. 2016;133:1761–71.
8.
Bonderman D, Wexberg P, Martischnig AM. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. Eur Respir J. 2011;37:1096–103.
9.
Olsson KM, Delcroix M, Ghofrani HA. Anticoagulation and survival in pulmonary arterial hypertension: results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA. Circulation. 2014;129:57–65.
10.
Galie N, Barbera JA, Frost AE. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med. 2015;373:834–44.
11.
Pulido T, Adzerikho I, Channick RN. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013;369:809–18.
12.
Lajoie AC, Lauziere G, Lega JC. Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis. Lancet Respir Med. 2016;4:291–305.
13.
D MC, S AC, C JLG. Multidetector computed tomography shows reverse cardiac remodeling after double lung transplantation for pulmonary hypertension. Radiologia. 2016;58:277–82.
14.
Tudorache I, Sommer W, Kuhn C. Lung transplantation for severe pulmonary hypertension-awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling. Transplantation. 2015;99:451–8.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by